CapsoVision, Inc. ( CV) - Key Metrics
CV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.15 | -$0.17 | -$0.17 |
| 2026Q1 | $0.06 | -$0.15 | -$0.13 | -$0.13 |
| 2025Q4 | $0.08 | -$0.16 | -$0.16 | -$0.16 |
| 2025Q3 | $0.08 | -$0.17 | -$0.12 | -$0.12 |
| 2025Q2 | $0.07 | -$0.10 | -$0.10 | -$0.10 |
CV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -0.16% | -12.63 |
| 2026Q1 | 0% | -12.15 |
| 2025Q4 | 0% | -8.10 |
| 2025Q3 | 0% | -7.12 |
| 2025Q2 | 0% | -8.77 |
CV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -2.22% | 0.00% |
| 2026Q1 | -1.77% | 0% |
| 2025Q4 | -1.53% | 0% |
| 2025Q3 | -2.54% | 0% |
| 2025Q2 | -2.81% | 0% |
CV
Price: $6.03
52 week price:
Earnings Per Share: -1.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 307.8 million